Search Results - Jan Vilsvik
- Showing 1 - 2 results of 2
-
1
Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer by Christian von Plessen, Bengt Bergman, Olga Andresen, R. M. Bremnes, Stein Sundstrøm, M Gilleryd, RJ Stephens, Jan Vilsvik, Ulf Aasebø, S Sörenson
Published 2006Artigo -
2
Irinotecan Plus Carboplatin Versus Oral Etoposide Plus Carboplatin in Extensive Small-Cell Lung Cancer: A Randomized Phase III Trial by Andreas Hermes, Bengt Bergman, Roy M. Bremnes, Lars Ek, Sverre Fluge, Christer Sederholm, Stein Sundstrøm, Lars Thaning, Jan Vilsvik, Ulf Aasebø, Sverre Sörenson
Published 2008Artigo
Search Tools:
Related Subjects
Carboplatin
Chemotherapy
Cisplatin
Internal medicine
Lung cancer
Medicine
Surgery
Cancer
Clinical endpoint
Colorectal cancer
Confidence interval
Etoposide
Gastroenterology
Hazard ratio
Irinotecan
Nursing
Oncology
Palliative care
Palliative chemotherapy
Performance status
Quality of life (healthcare)
Randomized controlled trial
Urology
Vinorelbine